企業プロフィール
Onconova Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- ONTX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
16.35 USD (-7.06%)
終値
最終更新: 2026年8月24日
—
時価総額
株価変動の要因
As of Aug 24, 2026, ONTX closed down 7.06% at $16.35. No new same-company headline was identified in the current news window.
企業概要
事業概要
Onconova Therapeutics is a development-stage oncology company focused on targeted cancer therapies and precision approaches to hard-to-treat malignancies. Its investment case comes from the possibility that a small set of programs can generate meaningful clinical and strategic value.
所在地とセクター分類
Onconova is headquartered in the United States and listed on NASDAQ, with a small-cap oncology biotech profile. It sits in the classic development-stage cancer-therapeutics category.
ビジネスモデルの特徴
The business depends on clinical progress, regulatory optionality, and capital preservation. Investors usually focus on proof-of-concept data, pipeline prioritization, and whether the company can extend its runway long enough to create value.
バイオ業界での位置付け
Onconova occupies a highly volatile oncology niche within biotech. Like many small cancer-drug developers, its stock can reprice sharply around data, financing, or partnership news.
今後のカタリスト
- Onconova is another legacy closeout name, with catalysts limited to any strategic or asset-disposition update. The market is mainly waiting for what value remains.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。